Abstract 3516: TriNKETs®: trispecific immune cell engager therapies exhibit potent preclinical in vivo anti-tumor activity and broad combinability in diverse cancer models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Colin LaCroix, Adam Stockmann, Mitchell Bigelow, Cornelis van der Poel, Jolanta Dubauskaite, Jeremy Beech, Samia Khan, Eva Gutierrez, Nathan Felix, Stuart W. Hicks, Nicolai Wagtmann, Ann F Cheung
Institution: Dragonfly Therapeutics (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409626657